Warning: Undefined array key "HTTP_ACCEPT_LANGUAGE" in C:\Apache24\htdocs\search\index.php on line 12

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in C:\Apache24\htdocs\search\index.php on line 12
YOSHIDA Kazushige|Shinshu University Researcher List

YOSHIDA Kazushige

Shinshu University Hospital Clinical Division of Orthopedic Surgery 

Assistant Professor 

Researcher Information

Degree

  • 医学博士, 信州大学

Research Keyword

    Osteogenesis Osteosarcoma PD-1

Field Of Study

  • Orthopedics Immunology
Research activity information

Award

  • 2021
    Raymond Sekiguchi MD – JMSA Scholarship
  • 2020
    信州大学運動機能学教室同門会賞

Paper

  • Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
    LouJin Song, Ramsey Bekdash, Kumi Morikawa, Jose R. Quejada, Alison D. Klein, Danielle Aina-Badejo, Kazushige Yoshida, Hannah E. Yamamoto, Amy Chalan, Risako Yang, Achchhe Patel, Dario Sirabella, Teresa M. Lee, Leroy C. Joseph, Fuun Kawano, Junco S. Warren, Rajesh K. Soni, John P. Morrow & Masayuki Yazawa
    Nature Cardiovascular Research, 1, 142-156, 2022
  • Antitumor Effect of Sclerostin against Osteosarcoma
    Hirokazu Ideta,Kazushige Yoshida,Masanori Okamoto,Jun Sasaki,Munehisa Kito,Kaoru Aoki,Yasuo Yoshimura,Shuichiro Suzuki,Atsushi Tanaka,Akira Takazawa,Hisao Haniu,Takeshi Uemura,Takashi Takizawa,Atsushi Sobajima,Takayuki Kamanaka,Jun Takahashi,Hiroyuki Kato andNaoto Saito
    CANCERS, 12(23), 6015, 2021
  • Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells
    Kazushige Yoshida, Masanori Okamoto, Jun Sasaki, Chika Kuroda, Haruka Ishida, Katsuya Ueda, Hirokazu Ideta, Takayuki Kamanaka, Atsushi Sobajima, Takashi Takizawa, Manabu Tanaka, Kaoru Aoki, Takesh
    BMC CANCER, 20(1), 2020
  • A Review of T-Cell Related Therapy for Osteosarcoma
    Kazushige Yoshida,Masanori Okamoto,Kaoru Aoki,Jun Takahashi andNaoto Saito
    Int J Mol Sci, 21(14), 4877, 2020
  • Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers
    Kazushige Yoshida 1 , Masanori Okamoto 1 , Jun Sasaki 1 , Chika Kuroda 2 , Haruka Ishida 2 , Katsuya Ueda 2 , Satomi Okano 2 , Hirokazu Ideta 1 , Takayuki Kamanaka 1 , Atsushi Sobajima 1 , T
    OncoTargets and Therapy, 12, 2513-2518, 2019
  • The interrelationship between anterior cruciate ligament tibial footprint and anterolateral meniscal root insertions: Quantitative, morphological and positional analyses using three-dimensional comput
    Keiji Tensho 1 , Tomoya Iwaasa 2 , Suguru Koyama 2 , Kazushige Yoshida 2 , Hiroki Shimodaira 2 , Hiroshi Horiuchi 2 , Hiroyuki Kato 2 , Naoto Saito 2 , Nanae Fukushima
    Knee, 26(5), 969-977, 2019
  • Organ accumulation and carcinogenicity of highly dispersed multi-walled carbon nanotubes administered intravenously in transgenic rasH2 mice
    Sobajima A, Haniu H, Nomura H, Tanaka M, Takizawa T, Kamanaka T, Aoki K, Okamoto M, Yoshida K, Sasaki J, Ajima K, Kuroda C, Ishida H, Okano S, Ueda K, Kato H, Saito N
    Int J Nanomedicine., 14, 6465-6480, 2019
  • Different aggregation and shape characteristics of carbon materials affect biological responses in RAW264 cells.
    Kuroda C, Ueda K, Haniu H, et al.
    Int J Nanomedicine., 13, 6079-6088, 2018
  • The status quo of treatment and clinical outcomes for patients over 80 years of age with high-grade soft tissue sarcoma: report from the soft tissue tumor registry in Japan.
    Okamoto M, Kito M, Yoshimura Y, et al.
    Japanese Journal of Clinical Oncology., 48(10), 900-905, 2018